EGFR and neoplasm: The aggressiveness of TNBC cells and poorer outcomes in patients with TNBC might be partly due to the enrichment of proinflammatory chemokines potentiated by the TGFα-EGFR-Akt signaling axis, which subsequently results in an increased inflammatory burden and produces a proinflammatory tumor microenvironment.